These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 14513811

  • 1. [Enhancement of gastrointestinal absorption of chitosan-coated insulin-loaded poly (lactic-co-glycolic acid) nanoparticles].
    Pan Y, Li YJ, Gao P, Ding PT, Xu H, Zheng JM.
    Yao Xue Xue Bao; 2003 Jun; 38(6):467-70. PubMed ID: 14513811
    [Abstract] [Full Text] [Related]

  • 2. [Study on preparation and oral efficacy of insulin-loaded poly(lactic-co-glycolic acid) nanoparticles].
    Pan Y, Xu H, Zhao HY, Wei G, Zheng JM.
    Yao Xue Xue Bao; 2002 May; 37(5):374-7. PubMed ID: 12579845
    [Abstract] [Full Text] [Related]

  • 3. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
    Sheng J, Han L, Qin J, Ru G, Li R, Wu L, Cui D, Yang P, He Y, Wang J.
    ACS Appl Mater Interfaces; 2015 Jul 22; 7(28):15430-41. PubMed ID: 26111015
    [Abstract] [Full Text] [Related]

  • 4. [Poly(arginine)8 enhanced intestinal absorption of insulin-loaded nanoparticles].
    Liu XL, Zhang WJ, Wei G, Lu WY.
    Yao Xue Xue Bao; 2012 Apr 22; 47(4):512-6. PubMed ID: 22799036
    [Abstract] [Full Text] [Related]

  • 5. Hydrophilic poly (ethylene glycol) capped poly (lactic-co-glycolic) acid nanoparticles for subcutaneous delivery of insulin in diabetic rats.
    S S, S M, P S L S, S S, S B, V P.
    Int J Biol Macromol; 2017 Feb 22; 95():1190-1198. PubMed ID: 27825822
    [Abstract] [Full Text] [Related]

  • 6. Oral insulin delivery, the challenge to increase insulin bioavailability: Influence of surface charge in nanoparticle system.
    Czuba E, Diop M, Mura C, Schaschkow A, Langlois A, Bietiger W, Neidl R, Virciglio A, Auberval N, Julien-David D, Maillard E, Frere Y, Marchioni E, Pinget M, Sigrist S.
    Int J Pharm; 2018 May 05; 542(1-2):47-55. PubMed ID: 29501738
    [Abstract] [Full Text] [Related]

  • 7. Novel PLGA-based nanoparticles for the oral delivery of insulin.
    Malathi S, Nandhakumar P, Pandiyan V, Webster TJ, Balasubramanian S.
    Int J Nanomedicine; 2015 May 05; 10():2207-18. PubMed ID: 25848248
    [Abstract] [Full Text] [Related]

  • 8. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
    Badran MM, Alomrani AH, Harisa GI, Ashour AE, Kumar A, Yassin AE.
    Biomed Pharmacother; 2018 Oct 05; 106():1461-1468. PubMed ID: 30119220
    [Abstract] [Full Text] [Related]

  • 9. Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates.
    Sheng J, He H, Han L, Qin J, Chen S, Ru G, Li R, Yang P, Wang J, Yang VC.
    J Control Release; 2016 Jul 10; 233():181-90. PubMed ID: 27178809
    [Abstract] [Full Text] [Related]

  • 10. Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo.
    Pan Y, Li YJ, Zhao HY, Zheng JM, Xu H, Wei G, Hao JS, Cui FD.
    Int J Pharm; 2002 Dec 05; 249(1-2):139-47. PubMed ID: 12433442
    [Abstract] [Full Text] [Related]

  • 11. HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin.
    Wu ZM, Zhou L, Guo XD, Jiang W, Ling L, Qian Y, Luo KQ, Zhang LJ.
    Int J Pharm; 2012 Apr 04; 425(1-2):1-8. PubMed ID: 22248666
    [Abstract] [Full Text] [Related]

  • 12. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin.
    Guo M, Rong WT, Hou J, Wang DF, Lu Y, Wang Y, Yu SQ, Xu Q.
    Nanotechnology; 2013 Jun 21; 24(24):245101. PubMed ID: 23702815
    [Abstract] [Full Text] [Related]

  • 13. Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes.
    Lee C, Choi JS, Kim I, Oh KT, Lee ES, Park ES, Lee KC, Youn YS.
    Int J Nanomedicine; 2013 Jun 21; 8():2975-83. PubMed ID: 23976850
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Surface-modified PLGA nanoparticles with chitosan for oral delivery of tolbutamide.
    Shi Y, Xue J, Jia L, Du Q, Niu J, Zhang D.
    Colloids Surf B Biointerfaces; 2018 Jan 01; 161():67-72. PubMed ID: 29040836
    [Abstract] [Full Text] [Related]

  • 16. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
    Kumar PS, Ramakrishna S, Saini TR, Diwan PV.
    Pharmazie; 2006 Jul 01; 61(7):613-7. PubMed ID: 16889069
    [Abstract] [Full Text] [Related]

  • 17. In vitro uptake evaluation in Caco-2 cells and in vivo results in diabetic rats of insulin-loaded PLGA nanoparticles.
    Reix N, Parat A, Seyfritz E, Van der Werf R, Epure V, Ebel N, Danicher L, Marchioni E, Jeandidier N, Pinget M, Frère Y, Sigrist S.
    Int J Pharm; 2012 Nov 01; 437(1-2):213-20. PubMed ID: 22940208
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Studies on the insulin-liposomes double-coated by chitosan and chitosan-EDTA conjugates].
    Wu ZH, Ping QN, Song YM, Lei XM, Li JY, Cai P.
    Yao Xue Xue Bao; 2004 Nov 01; 39(11):933-8. PubMed ID: 15696937
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.